|Table of Contents|

Biomechanical behavior of the occurrence and development of lung cancer and treatment level of traditional Chinese medicine

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 08
Page:
1573-1576
Research Field:
Publishing date:

Info

Title:
Biomechanical behavior of the occurrence and development of lung cancer and treatment level of traditional Chinese medicine
Author(s):
WANG Yuting1YAN Ran12XIAO Chong1ZHU Jie12YOU Fengming12
1.Hospital of Chengdu University of Traditional Chinese Medicine,Sichuan Chengdu 610075,China;2.Cancer Institute of Chengdu University of Traditional Chinese Medicine,Sichuan Chengdu 610075,China.
Keywords:
lung cancerbiomechanical behaviorDaqi in the chesttreatment level of traditional Chinese medicine
PACS:
R734.2
DOI:
10.3969/j.issn.1672-4992.2023.08.035
Abstract:
Lung cancer is affected by respiratory movement,which causes dynamic biomechanical changes due to different forces in different directions,as is the case with lung cancer cells."The Daqi in the chest" is the traditional Chinese medicine understanding of the biological power supporting the chest and lifting the lung,which usually shows three pathological stages:Qi deficiency,Qi leakage and Qi collapse.By analyzing the relationship between the abnormal biomechanical behavior of lung cancer cell "formation and proliferation-shedding and extravasation-migration and colonization" and the pathogenesis of "deficiency-leakage-collapse" of Daqi in the chest,it is suggested that the treatment of lung cancer in different stages should be based on three levels:"tonifying deficiency ","Qi catharsis is suitable for regulating and inducing" and "benefiting Qi ascending depression",in order to focus on the perspective of biomechanics and provide a new idea for traditional Chinese medicine treatment of lung cancer.

References:

[1]LIU QP,LUO Q,HALIM A,et al.Targeting lipid metabolism of cancer cells:A promising therapeutic strategy for cancer[J].Cancer Lett,2017,401(08):39-45.
[2]赵茜茜,田甜,闫婉君,等.中药干预肿瘤免疫微环境[J].现代肿瘤医学,2016,24(02):306-309. ZHAO XX,TIAN T,YAN WJ,et al.Regulating effects and molecular mechanisms of traditional Chinese medicine in the tumor immunity[J].Modern Oncology,2016,24(02):306-309.
[3]BALABAN NQ,SCHWARZ US,RIVELINE D,et al.Force and focal adhesion assembly:a close relationship studied using elastic micropatterned substrates[J].Nat Cell Biol,2001,3(5):466-472.
[4]MESSAL HA,ALT S,FERREIRA RMM,et al.Tissue curvature and apicobasal mechanical tension imbalance instruct cancer morphogenesis[J].Nature,2019,566(7742):126-130.
[5]HANAHAN D,WEINBERG RA.Hallmarks of cancer:the next generation[J].Cell,2011,144(5):646-674.
[6]BERTERO T,OLDHAM WM,GRASSET EM,et al.Tumor-stroma mechanics coordinate amino acid availability to sustain tumor growth and malignancy[J].Cell Metab,2019,29(1):124-140.e10.
[7]PARK JS,BURCKHARDT CJ,LAZCANO R,et al.Mechanical regulation of glycolysis via cytoskeleton architecture[J].Nature,2020,578(7796):621-626.
[8]刘贻尧.肿瘤细胞力学与力学生物学研究进展[J].医用生物力学,2018,33(S1):85-95. LIU YY.Research progress of tumor cell mechanics and mechanobiology[J].Journal of Medical Biomechanics,2018,33(S1):85-95.
[9]CHANVORACHOTE P,PONGRAKHANANON V,HALIM H.Caveolin-1 regulates metastatic behaviors of anoikis resistant lung cancer cells[J].Mol Cell Biochem,2015,399:291-302.
[10]ER EE,VALIENTE M,GANESH K,et al.Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization[J].Nat Cell Biol,2018,20(8):966-978.
[11]ZHU C,CHEN W,LOU JZ,et al.Mechanosensing through immunoreceptors[J].Nat Immunol,2019,20(10):1269-1278.
[12]冯瑞雪,张紫微,张再康.论张锡纯胸中大气下陷学说的形成[J].中医杂志,2016,57(17):1455-1459. FENG RX,ZHANG ZW,ZHANG ZK.Exploration and analysis of ZHANG Xichun's theory formation of Da Qi in the chest and the collapse[J].Journal of Traditional Chinese Medicine,2016,57(17):1455-1459.
[13]沈涛.中医肿瘤治法与方剂[M].北京:人民卫生出版社,2017:35. SHEN T.Traditional Chinese medicine tumor treatment and prescription [M].Beijing:People's Health Publishing House,2017:35.
[14]贺佐梅,黄惠勇,郜文辉,等.非小细胞肺癌病案证素分布规律及不同方法辨证结果的对比研究[J].北京中医药大学学报,2019,42(09):787-792. HE ZM,HUANG HY,GAO WH,et al.Comparative study on distribution of pattern elements and results of different methods of pattern differentiation in cases of non-small cell lung cancer[J].Journal of Beijing University of Traditional Chinese Medicine,2019,42(09):787-792.
[15]明海霞.黄芪多糖联合顺铂对Lewis肺癌小鼠的抑瘤作用及机制研究[D].兰州:甘肃农业大学,2016. MING HX.Research on mechanisms of antitumor effect on APS combining cisplatin for Lewis tumor-bearing mice[D].Lanzhou:Gansu Agricultural University,2016.
[16]熊绍权,李亚玲,罗秋月,等.大黄芪汤抑制化疗所致Lewis肿瘤肺转移作用及机制研究[J].成都中医药大学学报,2018,41(01):16-19. XIONG SQ,LI YL,LUO QY,et al.Effects and mechanisms of DaHuangQi decoction inhibit Lewis carcinoma lung metastasis induced by chemotherapeutics[J].J Chengdu Univ Tradit Chin Med,2018,41(01):16-19.
[17]明海霞,陈彦文,张帆,等.黄芪多糖联合顺铂处理降低Lewis肺癌移植瘤CD44表达并降低血清Ⅳ型胶原蛋白和透明质酸的水平[J].细胞与分子免疫学杂志,2015,31(07):909-913. MING HX,CHEN YW,ZHANG F,et al.Astragalus polysaccharides combined with cisplatin decreases the serum levels of CD44 and collagen type Ⅳ and hyaluronic acid in mice bearing Lewis lung cancer[J].Chin J Cell Mol Imm,2015,31(07):909-913.
[18]高静,毕蕾,江玉翠,等.人参水提液对TAMs与肿瘤细胞共培养体系肺癌A549细胞生物学行为的影响[J].中国中西医结合杂志,2017,37(03):345-350. GAO J,BI L,JIANG YC,et al.Effect of Water Extract of Ginseng on biological bechaviors of lung cancer A549 cells and the expression of F-actin in co-culture system of TAMs and A549 cells[J].Chin J Integr Trad West Med,2017,37(03):345-350.
[19]朱洁,许骏尧,吴颢昕.益气升提法的理论源流及临床应用探讨[J].中华中医药杂志,2016,31(11):4439-4441. ZHU J,XU JY,WU HX.Discussion on the theoretical origin and clinical application of benefiting vital qi for ascending method[J].China Journal of Traditional Chinese Medicine and Pharmacy,2016,31(11):4439-4441.
[20]苗婷婷.黄煌运用薯蓣丸治疗化疗后肺癌的临床经验[J].南京中医药大学学报,2016,32(2):198-200. MIAO TT.Clinical experience of Professor Huang Huang in treating lung cancer by using ShuyuWan[J].Journal of Nanjing University of Traditional Chinese Medicine,2016,32(2):198-200.
[21]王英,刘晓莹,张伟.固摄培本法治疗肺癌转移[J].中医学报,2018,33(6):938-941. WANG Y,LIU XY,ZHANG W.The treatment of lung cancer metastasis with consolidation and cultivating the foundation method[J].Acta Chinese Medicine,2018,33(6):938-941.
[22]谭晖,王吉昌,董丹凤,等.五味子酯甲通过抑制CCAT1和PI3K-AKT信号通路抑制肺癌细胞的迁移和侵袭[J].世界中医药,2021,16(13):1966-1971. TAN H,WANG JC,DONG DF,et al.Schisantherin a inhibits the migration and invasion of lung cancer cells by inhibiting the CCAT1 and PI3K-AKT signaling pathway[J].World Chinese Medicine,2021,16(13):1966-1971.
[23]黄大川,李祺福,李鹏,等.牡蛎低分子活性物质对人肺腺癌A549细胞的生物学效应[J].厦门大学学报(自然科学版),2002,41(05):614-617. HUANG DC,LI QF,LI P,et al.Effects of Oyster low molecular weight bioactive substance on the human lung adenocarcinoma A549 cells[J].Journal of Xiamen University (Natural Science),2002,41(05):614-617.
[24]梁盈,黄大川,石松林,等.牡蛎低分子活性肽对人肺腺癌A549细胞形态与超微结构变化的影响[J].厦门大学学报(自然科学版),2006,45(S1):177-180. LIANG Y,HUANG DC,SHI SL,et al.Effects of Oyster low molecular mass bioactive peptides on the morphology and ultrastucture of human lung adenocarcinoma A549 cell[J].Journal of Xiamen University (Natural Science),2006,45(S1):177-180.
[25]李晓红.升陷汤干预人肺腺癌细胞A549增殖的效应研究[D].成都:成都中医药大学,2020. LI XH.Effect of Shengxian decoction on the proliferation of human lung adenocarcinoma cell A549[D].Chengdu:Chengdu University of TCM,2020.
[26]李杰,花宝金,林洪生.从大气下陷理论探讨胸部恶性肿瘤术后症状的辨治[J].中医杂志,2014,55(21):1822-1825. LI J,HUA BJ,LIN HS.Discussion on syndrome differentiation and treatment of postoperative symptoms of thoracic malignant tumor from the theory of Qi collapse[J].Journal of Traditional Chinese Medicine,2014,55(21):1822-1825.
[27]姚丽芳.升陷汤加减治疗肺脾气虚型非小细胞肺癌相关性疲劳临床疗效[J].中华肿瘤防治杂志,2019,26(S1):60-61. YAO LF.Clinical effect of Shengxian Decoction on fatigue associated with lung spleen qi deficiency non-small cell lung cancer[J].Chin J Cancer Prev Treat,2019,26(S1):60-61.
[28]吴静远,许博文,李杰,等.基于网络药理学探讨升陷汤治疗非小细胞肺癌的分子生物学机制[J].世界中西医结合杂志,2021,16(03):490-499. WU JY,XU BW,LI J,et al.Exploring the molecular biological mechanism of Shengxian decoction in the treatment of non-small cell lung cancer based on network pharmacology[J].World Journal of Integrated Traditional and Western Medicine,2021,16(03):490-499.
[29]张旭辉,刘喜平,孙杰,等.升陷汤对肺纤维化大鼠肺组织α-平滑肌肌动蛋白、肺表面活性蛋白D及TGF-β1/Smads通路蛋白表达的影响[J].中国中医药信息杂志,2021,28(04):63-68 ZHANG XH,LIU XP,SUN J,et al.Effects of Shengxian decoction on expressions of α-smooth muscle actin,pulmonary surfactant protein D and TGF-β1/Smads pathway in lung tissue of rats with pulmonary fibrosis[J].Chin J Inf Tradit Chin Med,2021,28(04):63-68.
[30]赵连梅,孙佳玮,颜晰,等.中药升陷汤抑制肺癌A549细胞增殖和侵袭转移作用研究[J].中华中医药杂志,2011,26(09):2147-2150. ZHAO LM,SUN JW,YAN X,et al.Study for effect of Shengxiantang on invasion and metastasis of lung cancer A549 cell in vitro[J].China Journal of Traditional Chinese Medicine and Pharmacy,2011,26(9):2147-2150.

Memo

Memo:
四川省中医药重点学科建设项目-中医肿瘤病学(编号:2100601);成都中医药大学附属医院科研能力提升“百人计划”(编号:20-Y04)
Last Update: 1900-01-01